Skip to content

Clinical trial for the effect of the mobile devices assisted cognitive training for the post-stroke cognitive impairment

The multi-center randomized clinical trial for the effect of the mobile devices assisted cognitive training for the post-stroke cognitive impairment

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053562
Enrollment
Unknown
Registered
2021-11-24
Start date
2021-11-29
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Experimental group:mobile devices assisted cognitive training + conventional cognitive training

Sponsors

Huashan Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 30-75 years; 2. After cerebral infarction or cerebral hemorrhage, 1 month<=onset time<=12 months; 3. The diagnosis conforms to the diagnostic points of various cerebrovascular diseases adopted by the Fourth National Cerebrovascular Disease Academic Conference in 1995; 4. Patients who have suffered a stroke for the first time or have had no sequelae in the past; 5. Stroke confirmed by head CT or MRI examination and excluded other obvious neurological diseases (such as encephalitis, hydrocephalus, etc.); 6. Cognitive impairment is indicated by objective cognitive function evaluation, but the severity of cognitive impairment is not enough to make the patient unable to cooperate with evaluation and treatment (MoCA (Beijing version) total score 10-26 points); 7. Meet the diagnostic criteria for Post-Stroke Cognitive Impairment (PSCI), that is, the patient meets the criteria for cognitive impairment by objective assessment within 6 months after the clinical time of stroke; 8. No history of cognitive impairment caused by non-cerebrovascular disease (such as Alzheimer's disease, frontotemporal dementia, etc.); 9. Willing to cooperate with cognitive assessment, training and follow-up; 10. The patient himself or his immediate family signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe aphasia and difficult to cooperate with cognitive function assessment; 2. The number of years of formal education is less than 3 years; 3. Patients with serious primary diseases such as heart, liver, kidney and hematopoietic system; 4. Poorly controlled hypertension (quiescent systolic blood pressure > 180 mmHg or diastolic blood pressure > 110 mmHg, or dizziness, headache and other uncomfortable symptoms when blood pressure rises) or severe arrhythmia (such as frequent premature ventricular contractions); 5. Past history of mental disorders and drug abuse; 6. Stroke patients with major organ failure or critical illness, and diseases or states whose impact on the quality of life of patients exceeds that of post-stroke cognitive impairment; 7. Those who cannot complete the basic course of treatment, those who may have poor compliance (that is, those who cannot adhere to the treatment) and those who are difficult to follow up.

Design outcomes

Primary

MeasureTime frame
Total score of the Montreal cognitive assessment (MoCA);

Countries

China

Contacts

Public ContactWu Yi

Huashan Hospital of Fudan University

Wuyi@fudan.edu.cn+86 21 52887820

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026